Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(36:4e)/PE(36:3p) | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 159 | pmol/sample |
| - | PE(36:4e)/PE(36:3p) | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 228 | pmol/sample |
| - | PE(36:4e)/PE(36:3p) | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 199 | pmol/sample |
| - | PE(36:4e)/PE(36:3p) | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 81 | pmol/sample |
| - | PE(36:4e)/PE(36:3p) | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 79 | pmol/sample |
| - | PE(36:4e)/PE(36:3p) | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 90 | pmol/sample |
| - | PE(36:4e)/PE(36:3p) | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 287 | pmol/sample |
| - | PE(36:4e)/PE(36:3p) | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 359 | pmol/sample |
| - | PE(36:4e)/PE(36:3p) | C | 0.0 | BCD100322A01 | 130 | pmol/sample |
| - | PE(36:4e)/PE(36:3p) | C | 0.5 | BCD100322A03 | 209 | pmol/sample |
| - | PE(36:4e)/PE(36:3p) | C | 1.0 | BCD100322A07 | 258 | pmol/sample |
| - | PE(36:4e)/PE(36:3p) | C | 2.0 | BCD100322A11 | 279 | pmol/sample |
| - | PE(36:4e)/PE(36:3p) | C | 4.0 | BCD100322A15 | 78 | pmol/sample |
| - | PE(36:4e)/PE(36:3p) | C | 8.0 | BCD100322A19 | 86.9 | pmol/sample |
| - | PE(36:4e)/PE(36:3p) | C | 12.0 | BCD100322A23 | 97.2 | pmol/sample |
| - | PE(36:4e)/PE(36:3p) | C | 24.0 | BCD100322A27 | 319 | pmol/sample |
| - | PE(36:4e)/PE(36:3p) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 246 | pmol/sample |
| - | PE(36:4e)/PE(36:3p) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 298 | pmol/sample |
| - | PE(36:4e)/PE(36:3p) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 213 | pmol/sample |
| - | PE(36:4e)/PE(36:3p) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 86.1 | pmol/sample |
| - | PE(36:4e)/PE(36:3p) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 92.6 | pmol/sample |
| - | PE(36:4e)/PE(36:3p) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 307 | pmol/sample |
| - | PE(36:4e)/PE(36:3p) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 408 | pmol/sample |
| - | PE(36:4e)/PE(36:3p) | 25OH-Chol | 0.5 | BCD100322A04 | 201 | pmol/sample |
| - | PE(36:4e)/PE(36:3p) | 25OH-Chol | 1.0 | BCD100322A08 | 267 | pmol/sample |
| - | PE(36:4e)/PE(36:3p) | 25OH-Chol | 2.0 | BCD100322A12 | 116 | pmol/sample |
| - | PE(36:4e)/PE(36:3p) | 25OH-Chol | 4.0 | BCD100322A16 | 90.4 | pmol/sample |
| - | PE(36:4e)/PE(36:3p) | 25OH-Chol | 8.0 | BCD100322A20 | 83.6 | pmol/sample |
| - | PE(36:4e)/PE(36:3p) | 25OH-Chol | 12.0 | BCD100322A24 | 83 | pmol/sample |
| - | PE(36:4e)/PE(36:3p) | 25OH-Chol | 24.0 | BCD100322A28 | 368 | pmol/sample |